Is 6 months of androgen suppression therapy plus radiotherapy of benefit in patients with localized prostate cancer?

被引：0
|
作者：
Alan Pollack
Eric M Horwitz
机构：
[1] Chair of the Department of Radiation Oncology and Head of the Prostate Cancer Research Program at Fox Chase Cancer Center,
[2] Associate Professor and the Clinical Director of the Department of Radiation Oncology at Fox Chase Cancer Center in Philadelphia,undefined
来源：
Nature Clinical Practice Oncology | 2005年 / 2卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：12 / 13
页数：1
相关论文
共 50 条
  • [41] Should patients with localized prostate cancer receive primary androgen deprivation therapy?
    Namiki, Mikio
    Mizokami, Atsushi
    Akaza, Hideyuki
    NATURE CLINICAL PRACTICE UROLOGY, 2008, 5 (12): : 648 - 649
  • [42] Should patients with localized prostate cancer receive primary androgen deprivation therapy?
    Mikio Namiki
    Atsushi Mizokami
    Hideyuki Akaza
    Nature Clinical Practice Urology, 2008, 5 : 648 - 649
  • [43] Effects of Serum Testosterone Levels After 6 Months of Androgen Deprivation Therapy on the Outcome of Patients With Prostate Cancer
    Bertaglia, Valentina
    Tucci, Marcello
    Fiori, Cristian
    Aroasio, Emiliano
    Poggio, Massimiliano
    Buttigliero, Consuelo
    Grande, Susanna
    Saini, Andrea
    Porpiglia, Francesco
    Berruti, Alfredo
    CLINICAL GENITOURINARY CANCER, 2013, 11 (03) : 325 - +
  • [44] Intermittent androgen suppression in patients with prostate cancer
    de la Taille, A
    Zerbib, M
    Conquy, S
    Amsellem-Ouazana, D
    Thiounn, N
    Flam, TA
    Debré, B
    BJU INTERNATIONAL, 2003, 91 (01) : 18 - 22
  • [45] Mathematical Models of Androgen Resistance in Prostate Cancer Patients under Intermittent Androgen Suppression Therapy
    Baez, Javier
    Kuang, Yang
    APPLIED SCIENCES-BASEL, 2016, 6 (11):
  • [46] INTERMITTENT ANDROGEN DEPRIVATION THERAPY PLUS COMPREHENSIVE STEREOTACTIC RADIOTHERAPY FOR OLIGOMETASTATIC PROSTATE CANCER (CROP)
    Cheung, Patrick
    Tseng, Chia-Lin
    Chung, Hans
    Chu, William
    Vesprini, Danny
    Liu, Stanley
    Morton, Gerard
    Sahgal, Arjun
    Soliman, Hany
    Myrehaug, Sten
    Detsky, Jay
    Szumacher, Ewa
    Chung, Peter
    Helou, Joelle
    Emmenegger, Urban
    Mamedov, Alexandre
    Shahid, Anam
    Zhang, Liying
    Loblaw, Andrew
    RADIOTHERAPY AND ONCOLOGY, 2021, 163 : S23 - S23
  • [47] Intermittent Androgen Deprivation Therapy Plus Comprehensive Stereotactic Radiotherapy for Oligometastatic Prostate Cancer (CROP)
    Cheung, P.
    Tseng, C. L.
    Chung, H. R.
    Chu, W.
    Vesprini, D.
    Liu, S. K.
    Morton, G.
    Sahgal, A.
    Soliman, H.
    Myrehaug, S. D.
    Detsky, J.
    Szumacher, E.
    Chung, P.
    Helou, J.
    Emmenegger, U.
    Mamedov, A.
    Shahid, A.
    Zhang, L.
    Loblaw, D. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E267 - E268
  • [48] Androgen Deprivation Therapy and Definitive Radiotherapy for Prostate Cancer
    Mendenhall, William M.
    Henderson, Randal H.
    Hoppe, Bradford S.
    Nichols, Romaine Charles
    Mendenhall, Nancy P.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (05): : 530 - 534
  • [49] Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer
    Jones, Christopher U.
    Hunt, Daniel
    McGowan, David G.
    Amin, Mahul B.
    Chetner, Michael P.
    Bruner, Deborah W.
    Leibenhaut, Mark H.
    Husain, Siraj M.
    Rotman, Marvin
    Souhami, Luis
    Sandler, Howard M.
    Shipley, William U.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (02): : 107 - 118
  • [50] Targeted Androgen Pathway Suppression in Localized Prostate Cancer: A Pilot Study
    Mostaghel, Elahe A.
    Nelson, Peter S.
    Lange, Paul
    Lin, Daniel W.
    Taplin, Mary Ellen
    Balk, Steven
    Ellis, William
    Kantoff, Philip
    Marck, Brett
    Tamae, Daniel
    Matsumoto, Alvin M.
    True, Lawrence D.
    Vessella, Robert
    Penning, Trevor
    Merrill, Rachel Hunter
    Gulati, Roman
    Montgomery, Bruce
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03) : 229 - +
12345